Navigation Links
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
Date:5/13/2013

of lower loss from operations and higher common shares outstanding due to a public offering of shares of the Company's common stock in the first quarter of 2013, pursuant to which the Company raised net proceeds of approximately $42.7 million through the issuance of 69,696,970 shares of common stock.

As of March 31, 2013, the Company had cash, cash equivalents and short-term investments of $54.4 million, as compared to $24.8 million at December 31, 2012.  The increase in cash was primarily attributable of a public offering of shares of the Company's common stock in first quarter of 2013.  On April 5, 2013, the Company refinanced its long-term debt.  The new long-term debt has a principal amount of $20 million which amortizes at an average monthly cost of approximately $289,000 through October 2016, as compared to approximately $950,000 in monthly debt cost prior to the refinance.

On May 16, 2013 at 11:00 a.m. PDT, Anthera Pharmaceuticals, Inc. will hold its annual shareholder meeting at 1204 Burlingame Avenue #8, Burlingame, CA  94010.  Prior to the meeting the Company encourages all shareholders to cast their votes on proposals presented in the proxy materials. Our Shareholder Letter, Annual Report for the fiscal year ended December 31, 2012, as well as our Proxy Statement for the annual shareholder meeting scheduled for May 16, 2013, are available free of charge on our website at www.anthera.com. Interested parties can request a copy free of charge by calling Investor Relations at 510-856-5600 or sending an e-mail request to Investor Relations by accessing our website (www.anthera.com), selecting the "Investors" tab and then selecting "Investor Contact." Please include your contact information with the request.

Following the annual shareholder meeting, the Company will host a conference call on May 20, 2013 at 2:
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
2. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
3. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
4. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
5. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
6. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
7. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
8. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
9. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
10. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
11. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... DUBLIN, Ohio , July 24, 2014  As part ... owners, Cardinal Health will host its annual Pharmacy Ownership Boot ... Retail Business Conference in Washington, D.C. ... pharmacists the business knowledge and confidence needed to own their ... program has become the industry,s leading event for women pharmacists ...
(Date:7/24/2014)...  Xencor, Inc. (NASDAQ: XNCR ), a ... treatment of autoimmune diseases, asthma and allergic diseases, and ... results after market close on Thursday, July 31, 2014. ... the same day at 4:30 p.m. EDT (1:30 p.m. ... corporate update. The live call may be ...
(Date:7/24/2014)... MedVantx, Inc., the company that has ... in physician offices, MedStart Connect, today announced it ... medication non-adherence and hospital readmission rates specified in ... the Annals of Internal Medicine ... changes in generic medication pill color and shape ...
Breaking Medicine Technology:'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 3'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 4Xencor to Host Second Quarter 2014 Financial Results Webcast and Conference Call 2Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance 2Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance 3
... Mass., Aug. 31, 2011 Syndax Pharmaceuticals, Inc ... management will present at the following upcoming fall financial ... New York, NY, September 8 at 8:30 AM ET ... Zurich, Switzerland, September 13, 11:15 AM CEST oncology panel ...
... Fla., Aug. 31, 2011 A recent study featured ... dispels the myth that physicians, offices use prostate cancer ... The article, "Utilization Trends in Prostate Cancer ... of both surgical and radiation therapy for management of ...
Cached Medicine Technology:Syndax Pharmaceuticals to Present at Upcoming Fall Financial Conferences 2Study Explores Utilization Trends for Prostate Cancer Treatments 2
(Date:7/24/2014)... Texas at Arlington professor who co-authored a book ... in community revitalization has been awarded the Community ... Martinez-Cosio, associate professor in the School of Urban ... week at the society,s national conference, along with ... academic coordinator in the Urban Studies and Planning ...
(Date:7/24/2014)... sufficient to read the declaration of contents if you need ... to do this you need to be a highly skilled ... can look directly into the molecular structure of the various ... is almost both, as he has developed a method that ... samples. , The ,Fingerprints, of a Substance , ...
(Date:7/24/2014)... growing number of U.S. teens are using synthetic human ... ability, a new study finds. The percentage ... 11 percent in 2013 -- more than double the ... the Partnership for Drug-Free Kids revealed. The ... oversight of performance-enhancing substances and other "fitness" products, the ...
(Date:7/24/2014)... Recently, Stwd.co.uk, a professional supplier of wedding dresses and special ... new designs of cheap wedding dresses to its ... with big discounts. According to the CEO of the company, ... fashionable items. They are available at low rates, up to ... dress was previously priced at $150, and it is offered ...
(Date:7/24/2014)... 2014 Hayes, Inc. ( http://www.hayesinc.com ), ... use of evidence, is pleased to announce that Dee ... guest speaker at the AHRMM14 Conference in ... expert in value analysis who also serves as the ... Professionals (AHVAP), will facilitate and participate in two preconference ...
Breaking Medicine News(10 mins):Health News:Strategy for community development partnerships earns award for UT Arlington professor 2Health News:Chemist develops X-ray vision for quality assurance 2Health News:Chemist develops X-ray vision for quality assurance 3Health News:Dangerous Use of Growth Hormone Surges Among U.S. Teens 2Health News:Dangerous Use of Growth Hormone Surges Among U.S. Teens 3Health News:Dangerous Use of Growth Hormone Surges Among U.S. Teens 4Health News:Dangerous Use of Growth Hormone Surges Among U.S. Teens 5Health News:Cheap Wedding Dresses Are Offered by Stwd.co.uk at Low Prices 2Health News:Hayes, Inc. Senior Vice President to Speak at AHRMM14 Conference 2Health News:Hayes, Inc. Senior Vice President to Speak at AHRMM14 Conference 3
... Dr. Jane Carlton of the New York University School of ... , The one-celled bacterium is the causal organism ... transmitted and more severe among women. The infection is spread ... etc. ,In addition to causing uncomfortable itching in the ...
... normal life was affected by a parrot was rendered an amount ... used to work for a pet shop had fallen sick and ... like ordinary fever. But subsequent diagnosis revealed that he was suffering ... have direct contact with the sick African Grey but he is ...
... high levels of dangerous cholesterol in their blood.// ... of an experimental drug, AEGR-733, in six patients with ... to store bad cholesterol. The drug proved extremely beneficial ... be the most promising in the heap of prevalent ...
... implanted human emotions to a train was helpful to autistic ... conducted by Professor Simon Baron Cohen who is the director ... conducted among children in the age group of 4-8. ... there was a marked improvement in these children in recognizing ...
... witnessed a surge in the number of obesity surgeries, US statistics ... have gone up by 2000 percent amongst the 55 to 64 ... of 18 to 24. The procedures which are clubbed under the ... obese or who suffer chronic illnesses due to obesity. ...
... hundred villages in India will soon be well equipped ... centers - with the active involvement// of Indian American ... we would promote better hygiene, clean drinking water and ... also be given to creating awareness about vector borne ...
Cached Medicine News:Health News:Hypercholesterolemia Meets Its Match in an Experimental Drug 2Health News:Better Healthcare for 100 Villages - Courtesy Indian American Physicians 2
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm angled bevel up. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, angled bevel down. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Medicine Products: